ADVERTISEMENT

Sonali M. Smith, MD

Is Obinutuzumab Superior to Rituximab in Lymphoma? NO

Sonali M. Smith , MD;

10/20/2018

Magrolimab in Combination With Rituximab in Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 3-Year Follow-up Results From a Phase 1/2 Trial

Introduction:

Nancy L. Bartlett , MD;

Amitkumar Mehta ;

Nilanjan Ghosh , MD, PhD;

Leslie Popplewell ;

Graham P Collins ;

Ranjana Advani ;

Sonali M. Smith , MD;

Mark Roschewski , MD;

11/04/2022

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

See Full Calendar

Advertisement

Advertisement